JPH01100113A - External preparation for skin - Google Patents

External preparation for skin

Info

Publication number
JPH01100113A
JPH01100113A JP25673687A JP25673687A JPH01100113A JP H01100113 A JPH01100113 A JP H01100113A JP 25673687 A JP25673687 A JP 25673687A JP 25673687 A JP25673687 A JP 25673687A JP H01100113 A JPH01100113 A JP H01100113A
Authority
JP
Japan
Prior art keywords
skin
kojic acid
external preparation
protein
kojic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25673687A
Other languages
Japanese (ja)
Other versions
JP2575417B2 (en
Inventor
Yasuaki Oyama
康明 大山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP62256736A priority Critical patent/JP2575417B2/en
Publication of JPH01100113A publication Critical patent/JPH01100113A/en
Application granted granted Critical
Publication of JP2575417B2 publication Critical patent/JP2575417B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain external preparation for the skin having beautifying action, good feeling in use, spreading well on the skin, providing the skin with smooth luster, containing protein or a hydrolyzate thereof and kojic acid and an ester thereof. CONSTITUTION:An external preparation is blended with one or more of protein and a hydrolyzate thereof (e.g. soybean protein or collagen) and one or more of kojic acid and an ester thereof (e.g. kojic acid dipalmitate) and pharmaceutically manufactured by a conventional procedure to give the aimed substance. The amount of the proteins added is preferably 0.1-10wt.% and that of the kojic acids added is preferably 0.1-20wt.%. The substance may be pharmaceutically manufactured into various forms for external use of quasi-drugs such as emulsion, lotion, liniment or ointment besides cosmetic such as cream, cosmetic, pack or powder.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は美白作用を有すると共に使用感がよく、肌にな
じみ、肌になめらかなつやを与える皮膚外用剤に関する
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a skin preparation for external use that has a whitening effect, is comfortable to use, blends well with the skin, and gives smooth luster to the skin.

[従来の技術] 皮膚外用剤はローション、乳液、クリーム、パウダーな
どの形で化粧料や乳剤、リニメント剤、軟膏剤などに使
用されている。これらの皮膚外用剤は直接皮膚に塗布さ
れるので、皮膚との親和性や使用感が重要な性質とされ
ている。
[Prior Art] External skin preparations are used in cosmetics, emulsions, liniments, ointments, etc. in the form of lotions, milky lotions, creams, and powders. Since these external skin preparations are applied directly to the skin, their affinity with the skin and the feeling of use are considered important properties.

一方、コウジ酸またはそのエステルが安全で強い美白作
用を有していることも知られている。
On the other hand, it is also known that kojic acid or its esters are safe and have strong whitening effects.

[発明が解決しようとする問題点] 本発明は、コウジ酸またはそのエステルを用いた皮膚外
用剤が、従来の通常の処方では使用感や肌の状態におい
て必ずしも良好ではない点に鑑みなされたものであり、
塗布時のベタツキがなく、肌によくなじみ、肌をなめら
かにし、かつつやを与える皮膚外用剤を提供することを
目的とするものである。
[Problems to be Solved by the Invention] The present invention was developed in view of the fact that the conventional formulation of external skin preparations using kojic acid or its esters does not necessarily provide a good feeling of use and skin condition. and
The object of the present invention is to provide a skin preparation for external use that is not sticky when applied, blends well into the skin, makes the skin smooth, and gives a glossy glow.

[問題点を解決するための手段] かかる目的は、タンパク質またはその分解物の1種また
は2種以上とコウジ酸またはそのエステルの18または
2種以上とを含有させることにより達成される。
[Means for Solving the Problems] This object is achieved by containing one or more types of proteins or decomposition products thereof and 18 or more types of kojic acid or esters thereof.

[作用および実施例コ 本発明における一方の成分であるコウジ酸またはそのエ
ステルとしては、一般式: (式中、R1およびR2は同じかまたは異なり、水素原
子または炭素数3〜20個のアシル基である)で示され
るものが好ましい。
[Function and Examples] Kojic acid or its ester, which is one of the components in the present invention, has the general formula: ) are preferred.

エステルとしては、コウジ酸モノブチレート、コウジ酸
モノカプレート、コウジ酸モノパルミテート、コウジ酸
モノステアレート、コウジ酸モノシンナモエートまたは
コウジ酸モノベンゾエートなどのモノエステル、コウジ
酸ジブチレート、コウジ酸ジパルミテート、コウジ酸ジ
ステアレートまたはコウジ酸ジオレエートなどのジエス
テルが好ましい。モノエステルはコウジ酸の5位の水酸
基がエステル化されているものが好ましい。エステル化
するとメラニン生成抑制作用はコウジ酸と同等であるが
、pHや光に対する安定性が向上する。これらは、単独
で使用しても併用してもよい。
As esters, monoesters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid monostearate, kojic acid monocinnamoate or kojic acid monobenzoate, kojic acid dibutyrate, kojic acid dipalmitate, Diesters such as kojic acid distearate or kojic acid dioleate are preferred. The monoester is preferably one in which the hydroxyl group at the 5-position of kojic acid is esterified. When esterified, the melanin production inhibiting effect is equivalent to that of kojic acid, but the stability against pH and light is improved. These may be used alone or in combination.

他の成分であるタンパク質またはその分解物を皮膚外用
剤の配合成分として用いることも知られているが、所望
の効果をうるためには多量に配合する必要があり、多量
に用いると塗布時にベタツキが生じたり肌へのなじみが
わるくなることがある。しかし、このようなタンパク質
またはその分解物であってもコウジ酸またはそのエステ
ルと配合するときは塗布時のベタツキが抑えられ、肌へ
のすぐれた親和性と使用感を長期間保持することができ
る。
It is also known that proteins or their decomposition products, which are other ingredients, can be used as ingredients in external skin preparations, but in order to obtain the desired effect, they must be added in large amounts, and if used in large amounts, they may become sticky when applied. This may cause irritation or the product may not absorb well into the skin. However, when such proteins or their decomposition products are combined with kojic acid or its esters, stickiness during application is suppressed, and excellent affinity for the skin and feeling of use can be maintained for a long period of time. .

タンパク質またはその分解物としては、たとえば大豆タ
ンパク、小麦タンパク、グルテリン、グルカゴン、コラ
ーゲン、ゼラチン、エラスチン、卵白リゾチーム、フィ
ブリノーゲン、ミオシン、カゼイン、魚肉タンパクおよ
びそれらの塩などの1種または2種以上があげられ、こ
れらのタンパク質またはその分解物は単独で使用しても
併用してもよい。コウジ酸またはそのエステルの配合量
は外用剤中、通常0.01〜20%(重量%、以下同様
)好ましくは0.1〜2%であり、タンパク質またはそ
の分解物の配合量は通常0.01〜20%、好ましくは
0.1−10%である。
Examples of proteins or their decomposition products include one or more of soybean protein, wheat protein, glutelin, glucagon, collagen, gelatin, elastin, egg white lysozyme, fibrinogen, myosin, casein, fish protein, and salts thereof. These proteins or their decomposition products may be used alone or in combination. The amount of kojic acid or its ester in the external preparation is usually 0.01 to 20% (by weight, the same applies hereinafter), preferably 0.1 to 2%, and the amount of protein or its decomposition product is usually 0.01 to 20% (by weight, the same applies hereinafter). 01-20%, preferably 0.1-10%.

本発明の外用剤としては、たとえばクリーム、化粧料、
パック、パウダーなどの化粧料のほかに乳剤、ローショ
ン剤、リニメント剤、軟膏剤などの医薬部外品などの種
々の外用形態に製剤にでき、それぞれの製剤において常
用されている基剤、賦形剤、安定剤、顔料、香料、紫外
線吸収剤、酸化防止剤、防腐剤、金属封印剤、有機酸な
どを適宜配合してもよい。
External preparations of the present invention include, for example, creams, cosmetics,
In addition to cosmetics such as packs and powders, they can be formulated into various external forms such as emulsions, lotions, liniments, ointments, and other quasi-drugs, and the bases and excipients commonly used in each formulation. Agents, stabilizers, pigments, fragrances, ultraviolet absorbers, antioxidants, preservatives, metal sealants, organic acids, and the like may be added as appropriate.

つぎに実施例をあげて本発明の皮膚外用剤を説明するが
、本発明はかかる実施例のみに限定されるものではない
Next, the skin external preparation of the present invention will be explained with reference to Examples, but the present invention is not limited to these Examples.

実施例1 (クリーム) 重量部 (A)モノステアリン酸ポリオキシ エチレングリコール(40E、O,)     2.0
0自己乳化型モノステアリン酸 グリセリン           5.00ステアリン
酸           5.00べl\ニルアルコー
ル       1.00流動パラフイン      
   1.00トリオクタン酸グリセリル    0.
00コウジ酸ジパルミテート     2.00防腐剤
             適量谷  料      
               微量(B) 1 、3
−ブチレンブリコール     5.00水溶性コラー
ゲン        0゜30精製水        
     残余(製法) (A)に属する成分を加熱溶解する(油相)。
Example 1 (Cream) Part by weight (A) Polyoxyethylene glycol monostearate (40E, O,) 2.0
0 Self-emulsifying glyceryl monostearate 5.00 Stearic acid 5.00 Benyl alcohol 1.00 Liquid paraffin
1.00 Glyceryl trioctanoate 0.
00 Kojic acid dipalmitate 2.00 Preservative Appropriate amount
Trace amount (B) 1, 3
-Butylene glycol 5.00 Water-soluble collagen 0°30 Purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).

別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加し、撹拌乳化後、冷却してクリームをえ
た。
Separately, components belonging to (B) are dissolved by heating (aqueous phase). The water phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a cream.

実施例2(ローション) 重量部 ポリオキシエチレン硬化ヒマシ油 (60E、O,)              1.0
0エタノール            15.00クエ
ン酸              0,10クエン酸ナ
トリウム         0,301,3−ブチレン
グリコール      4.00コウジ酸      
       1.00工ラスチン加水分解物    
   0.10防腐剤              適
量香  料                    
  微量精製水              残余(製
法) 各成分を均一に撹拌、混合、溶解し、ローションをえた
Example 2 (Lotion) Part by weight Polyoxyethylene hydrogenated castor oil (60E, O,) 1.0
0 ethanol 15.00 citric acid 0,10 sodium citrate 0,30 1,3-butylene glycol 4.00 kojic acid
1.00 engineering lastine hydrolyzate
0.10 Preservatives Appropriate amount fragrance
Micro-purified water Residue (manufacturing method) Each component was uniformly stirred, mixed, and dissolved to obtain a lotion.

実施例3(乳液) 重量部 (A)ポリオキンエチレンベヘニルエーテル(20E、
O,)            0.50テトラオレイ
ン酸ポリオキシエチレ ンソルビツト(60E、O)         1.0
0親辿型モノステアリン酸グリセリン 1.00ステア
リン酸           0.50ベヘニルアルコ
ール        0.50アボガト浦      
      1.00天然ビタミンE        
    O,02コウジ酸モノパルミテート     
2.00防腐剤              適量香 
 料                     微量
(B) 1.3−ブチレングリコール      5.
00カルボキシビニルポリマー     0.10ゼラ
チン             5.00大豆タンパク
             0.50精製水     
         残余(製法) (A)に属する成分を加熱溶解する(油相)。
Example 3 (emulsion) Part by weight (A) Polyoquine ethylene behenyl ether (20E,
O,) 0.50 Polyoxyethylene sorbitate tetraoleate (60E, O) 1.0
0 Glyceryl monostearate 1.00 Stearic acid 0.50 Behenyl alcohol 0.50 Abogatoura
1.00 natural vitamin E
O,02 kojic acid monopalmitate
2.00 Preservatives Appropriate amount of fragrance
Material Trace amount (B) 1.3-Butylene glycol 5.
00 carboxyvinyl polymer 0.10 gelatin 5.00 soy protein 0.50 purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).

別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却して乳液をえた。
Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a milky lotion.

実施例4(ゼリー状パック) 重量部 クエン酸              0.20プロピ
レングリコール       4.Oa濃グリセリン 
          4.00エタノール      
       2.00カルボキシビニルポリマー  
   1.00炭酸カリウム           0
.80コウジ酸             0.50カ
ゼイン              6゜00防腐剤 
             適量香  料      
                微量精製水    
          残余(製法) 各成分を撹拌、混合、溶解してゼリー状パックをえた。
Example 4 (jelly pack) Part by weight Citric acid 0.20 Propylene glycol 4. Oa concentrated glycerin
4.00 ethanol
2.00 carboxyvinyl polymer
1.00 potassium carbonate 0
.. 80 Kojic acid 0.50 Casein 6゜00 Preservative
Appropriate amount of fragrance
micro purified water
Residue (manufacturing method) Each component was stirred, mixed, and dissolved to obtain a jelly-like pack.

実施例5 (クリーム状パック) 重量部 (Δ)ポリオキシエチレンベヘニルエーテル(20E、
o、)            t、o。
Example 5 (Cream pack) Part by weight (Δ) Polyoxyethylene behenyl ether (20E,
o,) t, o.

テトラオレイン酸ポリオキシエチレ ソルビッI−(40F、0.)         2.
00親油型モノステアリン酸グリセリン 2.00ベヘ
ニルアルコール        3.00スクワラン 
           25.00オクタン酸グリセリ
ン       10.00天然ビタミンE     
       O,04コウジ酸モノシンナモエート 
   2.00防腐剤              適
量香  料                    
  微量(B)1.3−ブチレングリコール     
 5.00小麦タンパク            3.
00クエン酸              0,04コ
ラ一ゲン加水分解物       0.10精製水  
            残余(製法) (A)に属する成分を加熱溶解する(油相)。
Tetraoleic acid polyoxyethylene sorbitol I-(40F, 0.) 2.
00 Lipophilic glycerin monostearate 2.00 Behenyl alcohol 3.00 Squalane
25.00 Glycerin octoate 10.00 Natural vitamin E
O,04 Kojic acid monocinnamoate
2.00 Preservatives Appropriate amount fragrance
Trace amount (B) 1,3-butylene glycol
5.00 wheat protein 3.
00 Citric acid 0.04 Collagen hydrolyzate 0.10 Purified water
Residue (manufacturing method) The components belonging to (A) are heated and dissolved (oil phase).

別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却してクリーム状パ
ックをえた。
Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain a cream pack.

実施例6(軟膏剤) 重量部 (A)モノステアリン酸ポリオキシエチレンソルビタン
([30E、O,)        1.00テトラオ
レイン酸ポリオキシエチレ ンソルビツト(80E、0.)         1.
50自己乳化型モノステアリン酸グリセ リン               1.50サラシミ
ツロウ          2.00パラフイン   
         2.00ステアリン酸      
     3.00ベヘニルアルコール       
 3.00シアバター            12.
00流動パラフイン          5.00天然
ビタミンE            O,04メチルポ
リシロキサン       0.01コウジ酸モノベン
ゾエート     3.00防腐剤         
    適量香  料               
      微量(B) 1 、3−ブチレングリコー
ル      5.00クエン酸          
    0,30グルテリン            
6.00精製水              残余(製
法) (A)に属する成分を加熱溶解する(油相)。
Example 6 (Ointment) Part by weight (A) Polyoxyethylene sorbitan monostearate ([30E, O,) 1.00 Polyoxyethylene sorbitan tetraoleate (80E, 0.) 1.
50 Self-emulsifying glycerin monostearate 1.50 White beeswax 2.00 Paraffin
2.00 stearic acid
3.00 behenyl alcohol
3.00 Shea butter 12.
00 Liquid paraffin 5.00 Natural vitamin E O,04 Methyl polysiloxane 0.01 Kojic acid monobenzoate 3.00 Preservative
Appropriate amount of fragrance
Trace amount (B) 1,3-butylene glycol 5.00 Citric acid
0,30 glutelin
6.00 Purified water Residue (manufacturing method) Heat and dissolve the components belonging to (A) (oil phase).

別に、(B)に属する成分を加熱溶解する(水相)。油
相に水相を添加して撹拌乳化後、冷却して軟膏剤をえた
Separately, components belonging to (B) are dissolved by heating (aqueous phase). The aqueous phase was added to the oil phase, emulsified by stirring, and then cooled to obtain an ointment.

実施例7(美白パウダー) 重量部 ミリスチン酸オクチルドデシル   1.0コウジ酸 
            2.0エラスチン     
       0.5香  料           
           微量マルチトール      
     残余(製法) 各成分を均一に撹拌、混合して美白パウダーをえた。
Example 7 (whitening powder) Part by weight Octyldodecyl myristate 1.0 Kojic acid
2.0 elastin
0.5 fragrance
trace maltitol
Residue (manufacturing method) Each ingredient was stirred and mixed uniformly to obtain a whitening powder.

実施例8(パネルテスト) 本発明の外用剤の効果をパネルテストにより確認した。Example 8 (panel test) The effectiveness of the external preparation of the present invention was confirmed by a panel test.

女性20名のパネラ−の上腕内側部に本発明の外用剤を
右腕に、対照外用剤を左腕に、1日2回(朝、夜)、3
0日間にわたって単純塗布した。
A panel of 20 women applied the topical preparation of the present invention to their right arm and the control topical preparation to their left arm, twice a day (morning and evening), three times a day.
Simple application was performed over a period of 0 days.

試験には実施例1のクリーム、実施例2のローション、
実施例3の乳液を用い、対照品には、それぞれの外用剤
からコウジ酸を除いたものを用いた。
The test included the cream of Example 1, the lotion of Example 2,
The emulsion of Example 3 was used, and as a control product, the respective external preparations with kojic acid removed were used.

試験終了後、ぞれの試験部位における塗布時のベタツキ
、肌のなめらかさ、肌へのなじみ、および肌のつやにつ
いて最も優れたものを5、最もわるいものを1とした5
段階で評価し、その平均値をとって比較した。結果を第
1表に示す。
After the test, the best one in terms of stickiness during application, skin smoothness, blending into the skin, and skin luster at each test site was given a 5, and the worst one was given a 1.
The results were evaluated in stages, and the average values were taken and compared. The results are shown in Table 1.

[以下余白] [発明の効果] 本発明の皮膚外用剤によるときは、塗布時のベタツキ、
肌のなめらかさ、肌へのなじみおよび肌のつやなどに好
ましい効果を発揮し、とくにベタツキおよび肌へのなじ
みの改善に著効を示す。
[Margin below] [Effects of the invention] When using the skin external preparation of the present invention, there is no stickiness at the time of application,
It exhibits favorable effects on skin smoothness, skin adhesion, and skin luster, and is particularly effective in improving stickiness and skin adhesion.

Claims (1)

【特許請求の範囲】[Claims] 1 タンパク質またはその分解物の1種または2種以上
とコウジ酸またはそのエステルの1種または2種以上と
を含有する皮膚外用剤。
1. A skin external preparation containing one or more proteins or their decomposition products and one or more kojic acid or esters thereof.
JP62256736A 1987-10-12 1987-10-12 External preparation for skin Expired - Lifetime JP2575417B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62256736A JP2575417B2 (en) 1987-10-12 1987-10-12 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62256736A JP2575417B2 (en) 1987-10-12 1987-10-12 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH01100113A true JPH01100113A (en) 1989-04-18
JP2575417B2 JP2575417B2 (en) 1997-01-22

Family

ID=17296729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62256736A Expired - Lifetime JP2575417B2 (en) 1987-10-12 1987-10-12 External preparation for skin

Country Status (1)

Country Link
JP (1) JP2575417B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256151A (en) * 1993-03-01 1994-09-13 Maruzen Pharmaceut Co Ltd Skin cosmetic
JP2002293738A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Cosmetic for improving photoaged skin
JP2002293739A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Skin function-improving agent
JP2002293740A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Hyaluronidase activity inhibitor
CN100358884C (en) * 2005-01-25 2008-01-02 上海奥利实业有限公司 Simple synthesis of kojic acid diester
JP2021517117A (en) * 2018-03-08 2021-07-15 シムライズ アーゲー Mixtures for the treatment of human skin and / or hair

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62108804A (en) * 1985-11-06 1987-05-20 Pola Chem Ind Inc Cosmetic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62108804A (en) * 1985-11-06 1987-05-20 Pola Chem Ind Inc Cosmetic

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256151A (en) * 1993-03-01 1994-09-13 Maruzen Pharmaceut Co Ltd Skin cosmetic
JP2002293738A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Cosmetic for improving photoaged skin
JP2002293739A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Skin function-improving agent
JP2002293740A (en) * 2001-03-30 2002-10-09 Sansho Seiyaku Co Ltd Hyaluronidase activity inhibitor
CN100358884C (en) * 2005-01-25 2008-01-02 上海奥利实业有限公司 Simple synthesis of kojic acid diester
JP2021517117A (en) * 2018-03-08 2021-07-15 シムライズ アーゲー Mixtures for the treatment of human skin and / or hair

Also Published As

Publication number Publication date
JP2575417B2 (en) 1997-01-22

Similar Documents

Publication Publication Date Title
KR920003328B1 (en) Whitening cosmetic composition
KR940000671B1 (en) Compositions for topical use having melanin synthesis-inhibiting activity
JPS63188609A (en) External preparation preventing coloring
JPH0725742A (en) Fair-skinning cosmetic
JPH07149612A (en) Composition for toilet article or dermatology
JP3597210B2 (en) Hair restoration
JP2844103B2 (en) External preparation for skin
JPH01100113A (en) External preparation for skin
JPH01100114A (en) External preparation for skin
JP2565516B2 (en) Topical skin
JPH0899860A (en) Skin external agent
JPS60116618A (en) Cosmetic
JPH0551314A (en) Skin cosmetics
JPH04321615A (en) Skin medicine for external use
JPS6231975B2 (en)
JPS6256411A (en) Beautifying agent
JPH10182404A (en) Preparation for external use for skin
JP2906269B2 (en) External preparation for skin
JP2000256173A (en) Emulsified cosmetic
JP2589761B2 (en) Cosmetic additives
JPH03200708A (en) Dermal external agent
JP2000191499A (en) Cosmetic for moisturiztng skin
JP2799600B2 (en) Oily cosmetic for skin
JPH0635378B2 (en) Cosmetics
JPH0363207A (en) Skin cosmetic

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term